Kunlu Zhao

机构：Southern Medical University

发表论文 7 篇 · 总被引 98 次 · h-index 4

代表论文

• Pharmacological evaluation of a novel skeleton compound isobavachin (4′,7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity (2023 · Bioorganic Chemistry · 被引 30)
• Piperine Improves Hyperuricemic Nephropathy by Inhibiting URAT1/GLUT9 and the AKT-mTOR Pathway (2024 · Journal of Agricultural and Food Chemistry · 被引 29)
• Protecting against ferroptosis in hyperuricemic nephropathy: The potential of ferrostatin-1 and its inhibitory effect on URAT1 (2024 · European Journal of Pharmacology · 被引 20)
• Febuxostat ameliorates APAP-induced acute liver injury by activating Keap1/Nrf2 and inhibiting TLR4/NF-κB p65 pathways (2023 · Experimental Biology and Medicine · 被引 10)
• Loss of Urat1 exacerbates APAP-induced liver injury in mice (2025 · Toxicology · 被引 4)
• Proline-derived quinoline formamide compounds as human urate transporter 1 inhibitors with potent uric acid-lowering activities (2024 · European Journal of Medicinal Chemistry · 被引 3)